Page last updated: 2024-11-05

tranexamic acid and Type 3 Von Willebrand's Disease

tranexamic acid has been researched along with Type 3 Von Willebrand's Disease in 3 studies

Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Saccullo, G1
Makris, M1
Boama, V1
Haynes, S1
Martín-Salces, M1
Jiménez-Yuste, V1
Álvarez-Román, MT1
Rivas-Pollmar, I1
Rodríguez de la Rúa, A1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Emicizumab for Severe VON Willebrand Disease (VWD) and VWD/Hemophilia A[NCT05500807]Phase 140 participants (Anticipated)Interventional2022-11-01Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

1 review available for tranexamic acid and Type 3 Von Willebrand's Disease

ArticleYear
Prophylaxis in von Willebrand Disease: Coming of Age?
    Seminars in thrombosis and hemostasis, 2016, Volume: 42, Issue:5

    Topics: Deamino Arginine Vasopressin; Factor VIII; Humans; Tranexamic Acid; von Willebrand Disease, Type 1;

2016

Other Studies

2 other studies available for tranexamic acid and Type 3 Von Willebrand's Disease

ArticleYear
Conservative management of a haemorrhagic adnexal cyst in a patient with Type 3 von Willebrand Disease.
    European journal of obstetrics, gynecology, and reproductive biology, 2011, Volume: 159, Issue:1

    Topics: Abdominal Pain; Adult; Antifibrinolytic Agents; Blood Component Transfusion; Coagulants; Factor VIII

2011
Management of delivery with FVIII/VWF concentrates in a pregnant woman with type 3 von Willebrand disease and alloantibodies.
    Thrombosis and haemostasis, 2012, Volume: 108, Issue:4

    Topics: Adult; Antifibrinolytic Agents; Blood Transfusion; Cesarean Section; Factor VIII; Female; Humans; In

2012